199 related articles for article (PubMed ID: 20820871)
1. Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression.
Chen MY; Clark AJ; Chan DC; Ware JL; Holt SE; Chidambaram A; Fillmore HL; Broaddus WC
J Neurooncol; 2011 May; 103(1):87-102. PubMed ID: 20820871
[TBL] [Abstract][Full Text] [Related]
2. IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling.
Oliva CR; Halloran B; Hjelmeland AB; Vazquez A; Bailey SM; Sarkaria JN; Griguer CE
Cell Commun Signal; 2018 Sep; 16(1):61. PubMed ID: 30231881
[TBL] [Abstract][Full Text] [Related]
3. Wilms' tumor 1 suppressor gene mediates antiestrogen resistance via down-regulation of estrogen receptor-alpha expression in breast cancer cells.
Han Y; Yang L; Suarez-Saiz F; San-Marina S; Cui J; Minden MD
Mol Cancer Res; 2008 Aug; 6(8):1347-55. PubMed ID: 18708366
[TBL] [Abstract][Full Text] [Related]
4. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
5. Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness.
Chidambaram A; Fillmore HL; Van Meter TE; Dumur CI; Broaddus WC
J Neurosurg; 2012 Apr; 116(4):843-53. PubMed ID: 22313360
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.
Werner H; Shen-Orr Z; Rauscher FJ; Morris JF; Roberts CT; LeRoith D
Mol Cell Biol; 1995 Jul; 15(7):3516-22. PubMed ID: 7791758
[TBL] [Abstract][Full Text] [Related]
7. Wilms' tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferation and apoptosis.
Kijima N; Hosen N; Kagawa N; Hashimoto N; Kinoshita M; Oji Y; Sugiyama H; Yoshimine T
Anticancer Res; 2014 Jan; 34(1):61-7. PubMed ID: 24403445
[TBL] [Abstract][Full Text] [Related]
8. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
[TBL] [Abstract][Full Text] [Related]
9. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418
[TBL] [Abstract][Full Text] [Related]
10. Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells.
Clark AJ; Ware JL; Chen MY; Graf MR; Van Meter TE; Dos Santos WG; Fillmore HL; Broaddus WC
J Neurosurg; 2010 Jan; 112(1):18-25. PubMed ID: 19392599
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
[TBL] [Abstract][Full Text] [Related]
12. WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene.
Mayo MW; Wang CY; Drouin SS; Madrid LV; Marshall AF; Reed JC; Weissman BE; Baldwin AS
EMBO J; 1999 Jul; 18(14):3990-4003. PubMed ID: 10406804
[TBL] [Abstract][Full Text] [Related]
13. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53.
Clark AJ; Chan DC; Chen MY; Fillmore H; Dos Santos WG; Van Meter TE; Graf MR; Broaddus WC
J Neurooncol; 2007 Jun; 83(2):163-72. PubMed ID: 17206472
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of Wilms' tumor gene WT-1 and elevated expression of insulin growth factor-II (IGF-II) and type 1 IGF receptor genes in prostatic stromal cells from patients with benign prostatic hyperplasia.
Dong G; Rajah R; Vu T; Hoffman AR; Rosenfeld RG; Roberts CT; Peehl DM; Cohen P
J Clin Endocrinol Metab; 1997 Jul; 82(7):2198-203. PubMed ID: 9215294
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
17. Silencing ZEB2 Induces Apoptosis and Reduces Viability in Glioblastoma Cell Lines.
Safaee S; Fardi M; Hemmat N; Khosravi N; Derakhshani A; Silvestris N; Baradaran B
Molecules; 2021 Feb; 26(4):. PubMed ID: 33572092
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor 1 enhances Cisplatin-resistance of advanced NSCLC.
Wu C; Wang Y; Xia Y; He S; Wang Z; Chen Y; Wu C; Shu Y; Jiang J
FEBS Lett; 2014 Dec; 588(24):4566-72. PubMed ID: 25447528
[TBL] [Abstract][Full Text] [Related]
19. Role of the Wilms' tumor 1 gene in the aberrant biological behavior of leukemic cells and the related mechanisms.
Li Y; Wang J; Li X; Jia Y; Huai L; He K; Yu P; Wang M; Xing H; Rao Q; Tian Z; Tang K; Wang J; Mi Y
Oncol Rep; 2014 Dec; 32(6):2680-6. PubMed ID: 25310451
[TBL] [Abstract][Full Text] [Related]
20. The WT1 Wilms' tumor suppressor gene is a downstream target for insulin-like growth factor-I (IGF-I) action in PC12 cells.
Sarfstein R; Werner H
J Neurochem; 2006 Nov; 99(3):818-26. PubMed ID: 16911581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
